We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAZZ icon
1701
Jazz Pharmaceuticals
JAZZ
$16B
$762K ﹤0.01%
4,782
+1,088
+29% +$159K
IYC icon
1702
iShares US Consumer Discretionary ETF
IYC
$1.22B
$760K ﹤0.01%
13,335
-3,447
-21% -$206K
PHDG icon
1703
Invesco S&P 500 Downside Hedged ETF
PHDG
$65M
$760K ﹤0.01%
23,535
+10,262
+77% +$348K
PHM icon
1704
Pultegroup
PHM
$24.6B
$758K ﹤0.01%
16,641
-10,595
-39% -$446K
QDEF icon
1705
FlexShares Quality Dividend Defensive Index Fund
QDEF
$564M
$758K ﹤0.01%
14,729
+2,650
+22% +$134K
TBLL icon
1706
Invesco Short Term Treasury ETF
TBLL
$2.85B
$758K ﹤0.01%
7,195
-1,715
-19% -$181K
NEWT icon
1707
NewtekOne
NEWT
$370M
$755K ﹤0.01%
46,433
+7,952
+21% +$132K
CHY
1708
Calamos Convertible and High Income Fund
CHY
$1.09B
$754K ﹤0.01%
71,461
+6,619
+10% +$73.7K
DB icon
1709
Deutsche Bank
DB
$72.4B
$753K ﹤0.01%
65,326
-126
-0.2% -$1.24K
PARAP
1710
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
$753K ﹤0.01%
30,409
+4,987
+20% +$144K
EG icon
1711
Everest Group
EG
$13.9B
$752K ﹤0.01%
2,271
+66
+3% +$20.6K
NREF
1712
NexPoint Real Estate Finance
NREF
$317M
$752K ﹤0.01%
47,308
+6,060
+15% +$104K
SNPS icon
1713
Synopsys
SNPS
$79B
$752K ﹤0.01%
2,354
-173
-7% -$54.1K
CPRT icon
1714
Copart
CPRT
$26.8B
$751K ﹤0.01%
24,658
-70
-0.3% -$2.1K
GIGB icon
1715
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$974M
$751K ﹤0.01%
16,987
-15,137
-47% -$664K
HTZ icon
1716
Hertz
HTZ
$838M
$751K ﹤0.01%
48,818
-2,175
-4% -$36.6K
PSCT icon
1717
Invesco S&P SmallCap Information Technology ETF
PSCT
$518M
$750K ﹤0.01%
18,777
-1,467
-7% -$59K
STK
1718
Columbia Seligman Premium Technology Growth Fund
STK
$940M
$750K ﹤0.01%
32,303
-2,928
-8% -$73.2K
UJUN icon
1719
Innovator US Equity Ultra Buffer ETF June
UJUN
$189M
$748K ﹤0.01%
27,913
-58
-0.2% -$1.56K
WSM icon
1720
Williams-Sonoma
WSM
$28.9B
$748K ﹤0.01%
13,020
+3,080
+31% +$185K
BMAY icon
1721
Innovator US Equity Buffer ETF May
BMAY
$237M
$746K ﹤0.01%
25,706
-5,700
-18% -$165K
FINX icon
1722
Global X FinTech ETF
FINX
$173M
$745K ﹤0.01%
38,695
-44,865
-54% -$904K
IDNA icon
1723
iShares Genomics Immunology and Healthcare ETF
IDNA
$208M
$745K ﹤0.01%
29,579
+627
+2% +$16.8K
GUT
1724
Gabelli Utility Trust
GUT
$583M
$741K ﹤0.01%
101,282
+31,437
+45% +$216K
HRB icon
1725
H&R Block
HRB
$6.87B
$741K ﹤0.01%
20,303
+2,180
+12% +$88.6K

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.